Company / Operating Cash Flow per Share
Exelixis Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$3.14
FY2025
5-year range
$0.66 / $3.14
FY2021-FY2025
Trend
+35.8%
vs FY2024
Sector context
#35 of 212
Health Care
What the data says
Exelixis's operating cash flow per share of $3.14 is higher than 83% of companies in the Health Care sector (FY2025). Operating Cash Flow per Share has increased for 3 consecutive years, from $0.66 in FY2022 to $3.14 in FY2025.
Based on SEC 10-K filings.
3.14 in FY2025 with a 5-year CAGR of +35.6%. Top quartile in the Health Care sector.
Improved from $1.03 to $3.14 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +68.6%
- 5-Year CAGR
- +35.6%
- 10-Year CAGR
- -
Sector benchmark
-40.5% below sector average
Key checks
Key Insights
- Exelixis's operating cash flow per share has grown for 3 consecutive years.
- In FY2025, operating cash flow per share increased 35.8% year-over-year.
- Ranks #35 out of 212 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 3.33 (safe zone, above 2.9 threshold)
- Strong profit margin: 29.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 31.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.14 | +35.8% |
| FY2024 | $2.31 | +124.7% |
| FY2023 | $1.03 | +57.0% |
| FY2022 | $0.66 | -61.2% |
| FY2021 | $1.69 | +146.7% |
| FY2020 | $0.69 | -61.0% |
| FY2019 | $1.76 | +147.4% |
| FY2018 | $0.71 | +24.4% |
| FY2017 | $0.57 | -38.1% |
| FY2016 | $0.92 | +227.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026